Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
The asset manager announced annual revenues rose 14%, topping $20 billion for the first time, with record net inflows of $641 billion.
It’s basic Newtonian physics, as Boeing just learned: When the sky falls for a company, so, too, will the bottom line.
The company’s struggle gives us a glimpse into how the wider world of voice assistants is trying to keep up with the technology zeitgest.